Amdocs Stock Z Score

DOX Stock

USD 86.31 0.18 0.21%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Amdocs Piotroski F Score and Amdocs Valuation analysis.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

At this time, Amdocs' Net Working Capital is fairly stable compared to the past year. Capital Lease Obligations is likely to rise to about 173.8 M in 2024, whereas Capital Surpluse is likely to drop slightly above 3.8 B in 2024. At this time, Amdocs' Interest Expense is fairly stable compared to the past year. Interest Income is likely to rise to about 25.7 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 181.9 M in 2024.

Amdocs Company Z Score Analysis

Amdocs' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Amdocs Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Amdocs is extremely important. It helps to project a fair market value of Amdocs Stock properly, considering its historical fundamentals such as Z Score. Since Amdocs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amdocs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amdocs' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Long Term Debt	Good Will	Intangible Assets	Property Plant Equipment	Short Term Investments	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Short Long Term Debt	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	0.2	0.77	0.15	0.93	0.94	0.81	0.04	0.94	0.53	0.53	0.92	-0.85	0.56	-0.15	-0.86	-0.59	-0.58	-0.58	0.58	0.52	-0.31	0.33
Total Stockholder Equity	0.96		-0.06	0.67	0.35	0.93	0.8	0.89	0.1	0.9	0.38	0.43	0.81	-0.93	0.35	-0.1	-0.82	-0.46	-0.48	-0.46	0.42	0.29	-0.25	0.19
Net Debt	0.2	-0.06		0.6	-0.62	0.13	0.48	-0.28	-0.23	0.26	0.41	0.64	0.45	0.2	0.85	-0.29	-0.37	-0.7	-0.64	-0.63	0.75	0.83	-0.46	0.59
Retained Earnings	0.77	0.67	0.6		-0.13	0.72	0.81	0.49	-0.07	0.85	0.54	0.79	0.81	-0.57	0.88	-0.19	-0.85	-0.81	-0.8	-0.7	0.85	0.75	-0.62	0.67
Accounts Payable	0.15	0.35	-0.62	-0.13		0.19	-0.08	0.44	-0.21	0.11	-0.35	-0.09	-0.04	-0.33	-0.45	0.1	-0.06	0.16	0.09	0.19	-0.32	-0.4	0.25	-0.31
Net Receivables	0.93	0.93	0.13	0.72	0.19		0.83	0.67	0.11	0.92	0.34	0.62	0.93	-0.82	0.42	-0.31	-0.89	-0.66	-0.67	-0.68	0.61	0.34	-0.49	0.26
Total Liab	0.94	0.8	0.48	0.81	-0.08	0.83		0.64	-0.05	0.89	0.64	0.58	0.93	-0.67	0.75	-0.18	-0.82	-0.67	-0.62	-0.64	0.7	0.73	-0.33	0.46
Total Current Assets	0.81	0.89	-0.28	0.49	0.44	0.67	0.64		0.07	0.72	0.43	0.09	0.52	-0.91	0.22	0.21	-0.55	-0.1	-0.12	-0.06	0.11	0.18	0.07	0.12
Short Term Debt	0.04	0.1	-0.23	-0.07	-0.21	0.11	-0.05	0.07		0.01	-0.07	-0.17	0.01	-0.13	-0.15	-0.46	-0.06	-0.04	0.16	0.18	-0.08	-0.21	-0.2	-0.15
Common Stock	0.94	0.9	0.26	0.85	0.11	0.92	0.89	0.72	0.01		0.47	0.62	0.92	-0.78	0.62	-0.16	-0.83	-0.65	-0.67	-0.62	0.74	0.59	-0.48	0.57
Current Deferred Revenue	0.53	0.38	0.41	0.54	-0.35	0.34	0.64	0.43	-0.07	0.47		0.23	0.46	-0.34	0.65	0.34	-0.41	-0.3	-0.24	-0.15	0.33	0.52	-0.06	0.35
Long Term Debt	0.53	0.43	0.64	0.79	-0.09	0.62	0.58	0.09	-0.17	0.62	0.23		0.73	-0.24	0.66	-0.38	-0.8	-0.89	-0.99	-0.86	0.83	0.56	-0.62	0.46
Good Will	0.92	0.81	0.45	0.81	-0.04	0.93	0.93	0.52	0.01	0.92	0.46	0.73		-0.63	0.65	-0.35	-0.89	-0.8	-0.78	-0.79	0.79	0.62	-0.53	0.45
Intangible Assets	-0.85	-0.93	0.2	-0.57	-0.33	-0.82	-0.67	-0.91	-0.13	-0.78	-0.34	-0.24	-0.63		-0.26	-0.03	0.67	0.25	0.28	0.28	-0.25	-0.15	0.18	-0.13
Property Plant Equipment	0.56	0.35	0.85	0.88	-0.45	0.42	0.75	0.22	-0.15	0.62	0.65	0.66	0.65	-0.26		-0.13	-0.61	-0.72	-0.66	-0.6	0.82	0.92	-0.49	0.74
Short Term Investments	-0.15	-0.1	-0.29	-0.19	0.1	-0.31	-0.18	0.21	-0.46	-0.16	0.34	-0.38	-0.35	-0.03	-0.13		0.38	0.62	0.4	0.55	-0.44	-0.18	0.52	-0.02
Treasury Stock	-0.86	-0.82	-0.37	-0.85	-0.06	-0.89	-0.82	-0.55	-0.06	-0.83	-0.41	-0.8	-0.89	0.67	-0.61	0.38		0.84	0.82	0.79	-0.69	-0.47	0.53	-0.25
Net Tangible Assets	-0.59	-0.46	-0.7	-0.81	0.16	-0.66	-0.67	-0.1	-0.04	-0.65	-0.3	-0.89	-0.8	0.25	-0.72	0.62	0.84		0.91	0.87	-0.87	-0.63	0.73	-0.45
Deferred Long Term Liab	-0.58	-0.48	-0.64	-0.8	0.09	-0.67	-0.62	-0.12	0.16	-0.67	-0.24	-0.99	-0.78	0.28	-0.66	0.4	0.82	0.91		0.89	-0.86	-0.58	0.63	-0.47
Short Long Term Debt	-0.58	-0.46	-0.63	-0.7	0.19	-0.68	-0.64	-0.06	0.18	-0.62	-0.15	-0.86	-0.79	0.28	-0.6	0.55	0.79	0.87	0.89		-0.83	-0.55	0.63	-0.35
Capital Surpluse	0.58	0.42	0.75	0.85	-0.32	0.61	0.7	0.11	-0.08	0.74	0.33	0.83	0.79	-0.25	0.82	-0.44	-0.69	-0.87	-0.86	-0.83		0.82	-0.73	0.79
Net Invested Capital	0.52	0.29	0.83	0.75	-0.4	0.34	0.73	0.18	-0.21	0.59	0.52	0.56	0.62	-0.15	0.92	-0.18	-0.47	-0.63	-0.58	-0.55	0.82		-0.32	0.79
Net Working Capital	-0.31	-0.25	-0.46	-0.62	0.25	-0.49	-0.33	0.07	-0.2	-0.48	-0.06	-0.62	-0.53	0.18	-0.49	0.52	0.53	0.73	0.63	0.63	-0.73	-0.32		-0.52
Capital Stock	0.33	0.19	0.59	0.67	-0.31	0.26	0.46	0.12	-0.15	0.57	0.35	0.46	0.45	-0.13	0.74	-0.02	-0.25	-0.45	-0.47	-0.35	0.79	0.79	-0.52

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Amdocs

According to the company's disclosures, Amdocs has a Z Score of 0.0. This is 100.0% lower than that of the IT Services sector and about the same as Information Technology (which currently averages 0.0) industry. The z score for all United States stocks is 100.0% higher than that of the company.

Amdocs ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amdocs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amdocs' managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Amdocs Institutional Holders

Institutional Holdings refers to the ownership stake in Amdocs that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amdocs' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amdocs' value.

		Shares
American Century Companies Inc	2023-12-31	2 M
Morgan Stanley - Brokerage Accounts	2023-12-31	1.7 M
Alliancebernstein L.p.	2023-12-31	1.7 M
State Street Corporation	2023-12-31	1.6 M
Vanguard Group Inc	2023-12-31	1.5 M
Brandes Investment Partners & Co	2023-12-31	1.4 M
Norges Bank	2023-12-31	1.4 M
Wellington Management Company Llp	2023-12-31	1.3 M
Principal Financial Group Inc	2023-12-31	1.2 M
Fmr Inc	2023-12-31	17.5 M
Hhg Plc	2023-12-31	6.5 M

Amdocs Fundamentals

	Return On Equity	0.16
	Return On Asset	0.071
	Profit Margin	0.11 %
	Operating Margin	0.15 %
	Current Valuation	10.28 B
	Shares Outstanding	116.5 M
	Shares Owned By Institutions	97.29 %
	Number Of Shares Shorted	1.89 M
	Price To Earning	19.03 X
	Price To Book	2.81 X
	Price To Sales	2.02 X
	Revenue	4.89 B
	Gross Profit	1.62 B
	EBITDA	920.59 M
	Net Income	542.96 M
	Cash And Equivalents	817.98 M
	Cash Per Share	6.74 X
	Total Debt	807.31 M
	Debt To Equity	0.23 %
	Current Ratio	1.60 X
	Book Value Per Share	30.55 X
	Cash Flow From Operations	822.63 M
	Short Ratio	2.57 X
	Earnings Per Share	4.68 X
	Price To Earnings To Growth	1.20 X
	Target Price	104.9
	Number Of Employees	29 K
	Beta	0.69
	Market Capitalization	10.06 B
	Total Asset	6.43 B
	Retained Earnings	6.55 B
	Working Capital	558.25 M
	Current Asset	2.1 B
	Current Liabilities	1.37 B
	Annual Yield	0.02 %
	Five Year Return	1.73 %
	Net Asset	6.43 B
	Last Dividend Paid	1.74

About Amdocs Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amdocs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Moving against Amdocs Stock

0.76	NN	Nextnav Acquisition Corp Tech Boost	Pair Corr
0.69	EGIO	Edgio Inc Report 17th of July 2024	Pair Corr
0.6	GB	Global Blue Group	Pair Corr
0.55	VERI	Veritone Financial Report 7th of May 2024	Pair Corr

The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.

The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:

How To Invest In Amdocs

Details

Is Amdocs Stock a good investment?

Details

What is Amdocs' Net Worth?

Details

Largest IT Consulting & Other Services Companies

View

Largest Software - Infrastructure Companies

View

Check out Amdocs Piotroski F Score and Amdocs Valuation analysis.

For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.

	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	CEOs Directory Screen CEOs from public companies around the world
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume

Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.18

Dividend Share

1.74

Earnings Share

4.68

Revenue Per Share

41.665

Quarterly Revenue Growth

0.05

The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amdocs Stock Z Score

Amdocs Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Amdocs Z Score Driver Correlations

Amdocs ESG Sustainability

Amdocs Institutional Holders

Amdocs Fundamentals

About Amdocs Fundamental Analysis

Pair Trading with Amdocs

Moving against Amdocs Stock

Complementary Tools for Amdocs Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY